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ARTICLE
Loss of testosterone impairs anti-tumor neutrophil
function
Janet L. Markman1, Rebecca A. Porritt1, Daiko Wakita1, Malcolm E. Lane1, Daisy Martinon1,
Magali Noval Rivas 1,2,3,4, Michael Luu5, Edwin M. Posadas6,7, Timothy R. Crother 1,2,3,4 &
Moshe Arditi 1,2,3,4✉
In men, the incidence of melanoma rises rapidly after age 50, and nearly two thirds of
melanoma deaths are male. The immune system is known to play a key role in controlling the
growth and spread of malignancies, but whether age- and sex-dependent changes in immune
cell function account for this effect remains unknown. Here, we show that in castrated male
mice, neutrophil maturation and function are impaired, leading to elevated metastatic burden
in two models of melanoma. Replacement of testosterone effectively normalized the tumor
burden in castrated male mice. Further, the aberrant neutrophil phenotype was also observed
in prostate cancer patients receiving androgen deprivation therapy, highlighting the evolu-
tionary conservation and clinical relevance of the phenotype. Taken together, these results
provide a better understanding of the role of androgen signaling in neutrophil function and
the impact of this biology on immune control of malignancies.
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In the United States, the incidence of melanoma is rising fasterthan any other preventable cancer1. With approximately70,000 new cases each year and over 10,000 deaths attributed
to the disease, Americans lose an average of 20.4 years of
potential life due to melanoma mortality2,3. Interestingly, the rate
of malignant melanoma is similar in men and women aged 15–45
years, but after age 50, the rate in males increases dramatically4,
and nearly two-thirds of melanoma deaths are male2. The loca-
tion of melanoma development also varies by sex, with males
typically having melanoma on the trunk region of the body,
whereas females more frequently develop melanoma on the legs5
and the odds of metastasis from thin lesions (≤1 mm) are three-
fold higher in men6. In a retrospective study analyzing metastatic
patterns from patients treated at a single center in Germany,
females had a higher incidence of locoregional metastasis and a
lower risk for distance metastasis (67.3% in females compared
with 73.8% in males)7. In addition, numerous studies have con-
firmed that sex is an independent prognostic factor even after
adjustment for Breslow thickness, histological subtype, body site,
age, ulceration, vascular invasion, mitotic rate, sentinel lymph
node positivity, and detection and diagnostic delay8–14. However,
the reason for the rise in melanoma incidence in aging males
remains to be elucidated.
The immune system is crucial for controlling malignancies.
Innate immune cells can both kill tumor cells and elicit an
adaptive immune response to eradicate tumors. However, the
immune system can also have a negative impact by releasing
factors that lead to tumor cell proliferation, angiogenesis, and
metastasis, and tumors may adapt to their environment and
selectively inhibit immune responses15. Harnessing the ability of
the immune system to detect and eliminate tumor cells is the
major goal of the nascent field of immunotherapy.
Many studies have documented important roles for sex hor-
mones in the development and function of the immune system.
For example, estrogen promotes the production of type 1 inter-
feron, and is known to affect the cycling of hematopoietic stem
cells and the development of dendritic cells16. Similarly, androgen
signaling has also been shown to play an important role in both
innate and adaptive immune processes, including macrophage
activation during wound healing, T and B cell development, and
neutrophil production17. However, the extent to which the
actions of these hormones underlie sex-specific vulnerabilities to
disease has remained unclear. Here, we used multiple syngeneic
metastatic mouse models to elucidate the underlying cause of the
sexual dimorphism in tumor burden in melanoma. We show that
compared with normal male mice, castrated mice have higher
rates of tumor formation, related to impaired maturation and
oxidative responsiveness of neutrophils. Testosterone replace-
ment reduces tumor burden in castrated mice, and bone marrow
transplant experiments demonstrate that the effect is due to
androgen signaling in immune cells. We observe that prostate
cancer (PCa) patients undergoing androgen deprivation therapy
also exhibit impairments in neutrophil maturation and function.
Taken together, these data illuminate the role of androgen sig-
naling in neutrophil function, and the potential impact of this
effect on cancer progression.
Results
Castration increases melanoma tumor burden in the lung. To
investigate the role of sex in melanoma, we used a syngeneic
mouse B16 melanoma model, in which expression of the tumor
suppressors p16Ink4a and p19Arf is lost18, a common occurrence
in human melanoma19. We found that female mice had increased
lung tumor burden compared with male mice (Fig. 1a, b). This
increased tumor burden occurred throughout the lung and not
only on the surface, as confirmed by melanin content quantifi-
cation and lung hematoxylin and eosin (H&E) staining (Sup-
plementary Fig. 1a–b). However, this divergence was only
observed in the experimental metastatic model, as subcutaneous
tumors grew at the same rate in male and female mice (Supple-
mentary Fig. 1c). To determine whether the elevated metastatic
burden in females was related to differences in weight, we
assessed B16 tumor growth in Ldlr−/− mice, which have a high
propensity to gain weight on a high fat diet (HFD)20. The
increased tumor burden in female mice was maintained in this
model, even in the setting of diet-induced weight gain and
increased cholesterol (Supplementary Fig. 1d–g).
We next performed ovariectomy and castration surgeries to
determine the impact of sex hormones during this process, and
found that the increased tumor burden observed in the lungs of
female mice was not dependent on progesterone or estrogen, as
ovariectomy did not affect tumor burden (Fig. 1c, d). However,
castration of male mice four weeks prior to tumor inoculation
resulted in increased tumor burden (Fig. 1e, f) and impaired survival
(Fig. 1g). Similar results were also observed in a second model of
melanoma, YUMM1.7 (derived from BrafV600E Cdkn2a−/− Pten−/−
GEMM mice)21 (Fig. 1h–j). Unlike humans, mouse adrenal glands
do not synthesize androgens22, so removal of the testes in these
models should result in full loss of testosterone production.
Importantly, although YUMM1.7 cells originated in a male mouse21
and do express the androgen receptor (AR) by qPCR but not by
western blot (Supplementary Fig. 1h–i), B16 cells are monosomic X23
and do not express AR by qPCR or by western blot (Supplementary
Fig. 1h–i), indicating that the effect of androgens on metastatic
growth is indirect and not related to the sex of the donor cells. We
further confirmed that the sex of the donor mouse was not
important, as YUMM3.1 cells (bearing the human mutations
BRAFV600Ewt/Cdkn2−/−), which were derived from a female
mouse, exhibited the same increased lung tumor burden following
tail vein injection (Supplementary Fig. 1j–k).
Castration impairs neutrophil maturation and function. We
next performed immune profiling of the lungs of B16 and
YUMM1.7 tumor-bearing mice to determine whether the differ-
ences in metastatic burden were related to differences in immune
response between sexes. As there were no differences between
the means of the two models and each had the same
significant findings, the average of both models is shown in Fig. 2.
We observed no differences between sham males, castrated
males, or females in the percent of lung-localized alveolar mac-
rophages, interstitial macrophages, dendritic cells, NK cells,
NKT cells, CD4+ T cells, or CD8+ T cells (Fig. 2a; Supplemen-
tary Fig. 2a). In agreement with these results, there were also no
significant differences in the percent of CD69-expressing
or CD44-expressing T or NKT cells, although the percent of
IFNγ-expressing NKT cells tended to be higher in sham male mice
(Fig. 2b; Supplementary Fig. 2b). To further investigate the role of
the adaptive immune response in susceptibility to metastases, we
implanted Rag1 KO mice, which lack B and T cells, with B16 via a
tail vein injection. Enhanced tumor burden in female mice was
preserved in this model (Fig. 2c, d), indicating that the sex dif-
ference is not dependent on adaptive immune function. Thus, we
more closely examined innate immune cells in our B16-implanted
wild type (WT) mice, revealing a decreased percentage and total
cell count of CD11b+Ly6G+ neutrophil infiltration in both
castrated and female mice (Fig. 2e, f). In addition, we observed in
both castrated and female mice decreased percentages and total
cell count of NK cells expressing IFNγ or CD69, which can trigger
cell-mediated cytolytic activity, proliferation, and release of cyto-
kines and granule contents24 (Fig. 2g, h). B16 cytotoxicity assays
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-15397-4
2 NATURE COMMUNICATIONS |         (2020) 11:1613 | https://doi.org/10.1038/s41467-020-15397-4 | www.nature.com/naturecommunications
revealed a non-significant trend towards increased cytotoxicity of
NK and neutrophils isolated from the lungs of male B16 tumor-
bearing mice compared to castrated males and females (Fig. 2i, j).
In naïve mice, a reduced percentage of neutrophils was observed
in castrated males, but not in female mice (Supplementary Fig. 2c),
while no other differences in other cells types were observed
(Supplementary Fig. 2d).
Since we observed a decrease in the percentage of neutrophils
in castrated male and female mice compared with sham male
mice (Fig. 2e), we next assessed if neutrophils contributed to the
B1
6 
co
lo
ni
es
 in
 lu
ng
0
100
200
300
400
500
600
700
Male
Female + sham
Female + ovariectomy
p = 0.0137 
a bB16
Male Female
B16
Male
Female
(ovariectomy)
Female
(sham)
B16
Male
(sham) Female
Male
(castration)
YUMM1.7
Male
(sham) Female
Male
(castration)
c d
e f
g h
i j
Time (days)
B1
6:
 p
er
ce
nt
 s
ur
viv
al
0
0
50
100
20 22 24 26 28 30
Male + sham
Male + castration
Female
Time (days)
YU
M
M
1.
7:
 p
er
ce
nt
 s
ur
vi
va
l
0
0
50
100
25 30 35 40 45
Male + sham
Male + castration
Female
B1
6 
co
lo
ni
es
 in
 lu
ng
0
200
400
600
800
Female
Male
p = 0.0002
B1
6 
co
lo
ni
es
 in
 lu
ng
0
100
200
300
400
500
Male + sham
Male + castration
Female
YU
M
M
1.
7 
co
lo
ni
es
 in
 lu
ng
0
50
100
150
Male + sham
Male + castration
Female
p = 0.0068 
p = 0.0029 
p < 0.0001
p < 0.0001 p < 0.0001
p < 0.0001
p = 0.0002 
p = 0.0002 
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-15397-4 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:1613 | https://doi.org/10.1038/s41467-020-15397-4 |www.nature.com/naturecommunications 3
tumor burden differences between the sexes. Depletion of
neutrophils with anti-Ly6G antibody (αLy6G) resulted in
increased tumor burden in male mice, but not female mice
(Fig. 3a, b; Supplementary Fig. 3a). Interestingly, neutrophil
depletion also led to a significant reduction in IFNγ-producing
NK cells in males (Fig. 3c), indicating cross-talk between
neutrophils and NK cells. In vivo depletion of NK cells with an
anti-NK1.1 antibody (αNK1.1) elicited a significant increase in
tumor burden in both male and female mice, suggesting that NK
cells play an important role in blocking tumor growth in both
sexes (Supplementary Fig. 3b–d). Thus, although NK cells are
crucial for the killing of B16 cells, NK cells do not participate in
the observed sex difference in experimental metastases between
male and female mice.
In an effort to understand the sex differences in neutrophil
phenotypes, we analyzed their maturation and functional states.
Neutrophils can be divided into subtypes based on their
maturation levels25. Immature neutrophils include myelocytes,
which mature into meta-myelocytes, and then into banded
neutrophils. Neutrophils are considered mature once the nucleus
becomes segmented25. We found that tumor-bearing sham male
mice had an increased percentage of mature, segmented
neutrophils compared with both castrated and female mice
(Fig. 3d; Supplementary Fig. 3e). However, this difference was not
observed in naïve mice, indicating that it is not an intrinsic
difference (Supplementary Fig. 3f). As neutrophils mature in the
bone marrow, CXCR2 expression increases, whereas the expres-
sion of CXCR4 and VLA-4 decrease26. Consistent with this
model, neutrophils isolated from the bone marrow of tumor
bearing castrated male mice expressed lower CXCR2 mRNA
levels and higher CXCR4 and VLA-4 mRNA levels compared
with those from sham male mice (Supplementary Fig. 3g).
Similarly, female-derived neutrophils had decreased expression of
CXCR2 and increased expression of VLA-4, but there was no
difference in CXCR4 (Supplementary Fig. 3g). CD62L expression,
which correlates with CXCR2 and inversely correlates with
CXCR426, was also lower in neutrophils isolated from castrated
and female mice compared with male mice (Supplementary
Fig. 3g). Finally, STAT3 expression, which impacts the retention
and release of neutrophils in the bone marrow27, was similarly
decreased in castrated and female-derived neutrophils and may
underlie the reduced neutrophil chemotaxis to the lung in those
groups (Supplementary Fig. 3g).
To elucidate the effects of testosterone signaling via AR in
neutrophils, we performed a profiler qPCR array of AR signaling
targets in isolated neutrophils from sham and castrated male
mice. Of the 84 genes tested, 40 genes were upregulated, while
only 4 genes were downregulated in the neutrophils from
castrated males (>2-fold difference between groups), indicating
that the AR signaling pathway in neutrophils is active and
aberrant in castrated male mice compared with sham (Supple-
mentary Fig. 3h). Interestingly, castration resulted in upregulation
of AR in neutrophils, which has previously been shown in
prostate cancer cells treated with an AR antagonist28. As an
additional control, we isolated prostate tissue from sham and
castrated males and performed the qPCR array of AR signaling
targets. In direct contrast to isolated neutrophils, and as expected,
53 AR signaling genes were downregulated in castrated males,
while only 5 genes were upregulated (>2-fold difference
between the group; Supplementary Fig. 3i). Validation of selected
markers in neutrophils from castrated males and females
(Supplementary Fig. 3j) confirmed our results.
We next assessed neutrophils’ ability to generate reactive
oxygen species (ROS). Oxidative burst occurs during phagocy-
tosis and in response to soluble agonists, and while this action is
important for host defense, it can also damage surrounding
tissues29. Unstimulated neutrophils isolated from the lungs of
tumor-bearing castrated and female mice had an increased
percent of dihydrohodamine 123 (DHR123)-producing cells,
which measures production of H2O2 (Fig. 3e; Supplementary
Fig. 3k). However, upon stimulation with PMA, a significantly
increased percent of sham male neutrophils produced ROS
compared with neutrophils from castrated and female mice
(Fig. 3f). The enhanced percent of ROS-producing male
neutrophils in response to PMA was also observed in naïve mice
(Supplementary Fig. 3l–m), indicating that neutrophils from
castrated mice have an innate defect in responding to stimuli. In
addition, neutrophils from the lungs of male B16-tumor bearing
mice exhibited enhanced phagocytosis of FITC-labeled zymosan
beads (Fig. 3g), again indicating a more efficient response to
stimuli. We also performed immunohistochemistry to determine
the distance of neutrophils within 100 µM of a B16 tumor nodule
in the lung. Neutrophils in sham male mice were found to be in
contact with the tumor, which is represented by a distance of 0
µM, more often (47%) than in castrated male (26%) or female
mice (17%), with a significant difference in distance in sham male
compared with female mice, and a similar trend in castrated mice
(Fig. 3h). While we do not know the function of these
neutrophils, these results warrant further investigation in future
studies.
To further elucidate whether it was the hormonal environment
or the sex of the immune cells that accounted for this effect, bone
marrow transplants (BMT) were performed in which C57BL/6
male mice received either male (control) or female CD45.1+BM,
and female mice received female (control) or male CD45.1+ BM
(Supplementary Fig. 3n). Male mice receiving either male or
female BM still had decreased lung tumor burden (Fig. 3i–j),
increased neutrophil infiltration (Fig. 3k), and an increased
percent of DHR123-producting neutrophils following stimulation
(Fig. 3l) compared with female recipient mice, indicating that the
hormonal environment, rather than the sex of the immune cell,
underlies the sex differences in immune response.
Physiological testosterone reverses the castrated phenotype. To
determine the impact of testosterone (T) on the observed sex
differences in melanoma tumor burden in the lung, 1.5 mg T
Fig. 1 Melanoma tumor burden in the lungs of female and castrated male mice is higher than in sham male mice in experimental metastatic models.
Representative images of lungs (a) and numbers of tumor colonies (b) in the lungs of male and female C57Bl/6 mice following a B16 tail-vein injection
(n= 13 per group). Representative images of lungs (c) and numbers of tumor colonies (d) in the lungs of B16-injected males, sham females, and females
following ovariectomy (n= 5 per group). Representative images of lungs (e) and numbers of tumor colonies (f) in the lungs of B16-injected sham males,
castrated males, and female mice (n= 6 per group). g Survival curve following tail-vein injection with B16 melanoma cells (n= 9 male+sham and male
+castration; n= 10 female). Representative images of lungs (h) and tumor colonies numbers (i) in YUMM1.7 injected sham males, castrated males, and
female mice (n= 10 per group). j Survival curves following tail-vein injections of YUMM1.7 melanoma cells (n= 10 male+sham and male+castration; n=
9 female). Data in b, d, f, and i are mean ± s.e.m. by two-tailed unpaired t test (a) and 1-way ANOVA ith Bonferoni post-tests analysis (d, f, and i). Survival
curve analysis (g, j) was performed using the two-sided Log-rank (Mantel-Cox) test. Data in a–b and e–f are representative of at least 3 independent
experiments; data in c–d and h–j are representative of 2 independent experiments. The scale bar represents 0.5 cm for images of lung.
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pellets were implanted at the time of castration to replicate
physiological levels (Supplementary Fig. 4a). While castration led
to an increase in tumor burden, testosterone replacement
decreased tumor burden to the level seen in sham male mice, and
neutrophil infiltration similarly increased to sham levels
(Fig. 4a–c). As androgens have been reported to be immuno-
suppressive30, we also assessed the effect of high dose T at the
time of castration, and found that indeed tumor burden did
increase (Supplementary Fig. 4b–c), although the percentage of
DHR123-producing neutrophils following stimulation was
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similar among sham and both T supplemental concentrations
(Supplementary Fig. 4d). These data indicate that T may be
beneficial to the immune response at physiologic levels, but
detrimental at super-physiologic doses. Interestingly, supple-
menting female mice with a low-dose T pellet also caused a small
decrease in tumor burden (Supplementary Fig. 4e–f). In addition,
we implanted YUMM1.7 cells into the right flanks of mice and
allowed the cells to spontaneously metastasize to the lung. In
agreement with the subcutaneous B16 model (Supplementary
Fig. 1c), there was no significant difference in primary tumor size
between sham male and female mice (Fig. 4d). However, there
was a non-significant trend towards an increased number of
YUMM1.7 colonies in the lungs of female mice (Fig. 4e). In
comparison, castrated males had both a significantly increased
primary tumor volume (Fig. 4d) and increased number of
YUMM1.7 metastatic colonies in the lung compared with sham
and castrated males with T supplementation (Fig. 4e). While
there was not a large number of metastatic colonies found in any
mouse as they reached euthanasia criteria early due to the size of
the subcutaneous tumors, these data do show an increased fre-
quency and number of micro-metastases, again supporting the
protective role that T has in preventing metastatic spread of
melanoma to the lung.
Previously, AR deficient mice were shown to suffer from
neutropenia due to reduced proliferative activity of neutrophil
precursor cells31. In line with this, T replacement at a physiologic
dose prior to tumor inoculation produced a trend towards
increased circulating neutrophils in both male and female mice,
whereas castration alone decreased the number of neutrophils
(Supplementary Fig. 4g).
BMT with AR−deficient mice reflects the castrated phenotype.
In testicular feminization (ARTfm) mice, the translation of AR is
prematurely terminated due to a single nucleotide deletion of
exon 132. These mice appear female, have very small testes, and
do not develop androgen-producing Leydig cells properly33. We
performed a BMT with male ARTfm donors to Ly5.1 C57BL/6
WT male recipients to determine if the presence of AR on
immune cells impacted tumor burden. Indeed, the B16 tumor foci
count in lungs of mice that received ARTfm BM was increased
compared with control C57BL/6 WT recipients (Fig. 4f–g). Sur-
prisingly, neutrophil infiltration in the lung was not changed
between the two groups (Fig. 4h). However, analysis of neutrophil
function revealed an increased percentage of DHR123-producing
neutrophils in unstimulated ARTfm recipients (Fig. 4i), but a
decreased percentage when neutrophils were stimulated (Fig. 4j).
In addition, only 35.1% of isolated neutrophils from naive ARTfm
mice were morphologically segmented, mature neutrophils
(Supplementary Fig. 4h), compared with greater than 80% in WT
male mice (Supplementary Fig. 3f). These data indicate that the
maturation and function of neutrophils is impacted by the
presence of AR on neutrophils, and loss of AR decreases their
anti-tumor potential.
Anti-androgen treatment results in increased tumor burden. In
order to confirm our castration data, we treated mice with flu-
tamide, a non-steroidal anti-androgen that works by directly
binding AR to prevent testosterone signaling34. We sub-
cutaneously implanted both male and female mice with either a
placebo pellet or a 100 mg, 21 day release flutamide pellet one
week prior to injecting B16 cells in the tail vein. Male mice
receiving the flutamide pellet exhibited increased tumor burden
(Fig. 4k–l) and a decreased percentage of neutrophils in the lungs
(Supplementary Fig. 4i) compared with male mice implanted with
placebo pellets. Female mice with flutamide pellets also had
increased tumor burden compared with female mice bearing
placebo pellets (Supplementary Fig. 4j–k These data further
confirm that a lack of testosterone signaling increases tumor
burden in the lung in an experimental metastasis model of
melanoma.
ADT-treated PCa patients exhibit neutrophil impairments. In
order to investigate if T plays a role in human neutrophil biology,
we isolated neutrophils from prostate cancer (PCa) patients
undergoing androgen deprivation therapy (ADT), or not cur-
rently undergoing treatment (controls) (Supplementary Table 1).
Morphological analysis of circulating patient neutrophils revealed
a decreased number of segmented, mature neutrophils in ADT
patients (Fig. 5a; Supplementary Fig. 5a). Immune markers
including CD16 have been shown to be crucial for antibody-
dependent cellular cytotoxicity for the killing of both primary
cancers and cancer cell lines35. Indeed, the presence of CD16+
infiltrating myeloid cells is associated with increased survival in
patients with colorectal cancer36. Further, a significant decrease in
CD16 expression on infiltrating neutrophils was shown in inva-
sive cervical cancer compared with low grade lesions37. We
observed a similar decrease in CD16hi neutrophils in ADT-
treated prostate cancer patients (Fig. 5b; Supplementary Fig. 5b).
A trend towards increased myeloid-derived suppressor cells
(MDSC)-like neutrophils, defined as HLA-DR-CD14−
CD33+CD15+38, was also observed in ADT treated patients
(Fig. 5c; Supplementary Fig. 5c). We did not find any difference
in the invasion ability of the neutrophils between the two groups
(Fig. 5d; Supplementary Fig. 5d). However, consistent with the
mouse data, an increased percentage of human neutrophils from
patients on ADT exhibited production of ROS (DHR123) at
baseline (Fig. 5e; Supplementary Fig. 5e) but these cells had
impaired response to PMA (Fig. 5f). There was also a striking
increase in the percentage of myeloperoxidase (MPO) positive
neutrophils in ADT patients (Fig. 5g; Supplementary Fig. 5f).
MPO production is crucial in an antimicrobial response, but
enhanced levels are associated with high inflammation and
Fig. 2 Sham male mice have increased neutrophil infiltration and NK cell activation in the lungs of melanoma injected mice. a Average immune cell
content in the lungs of B16 and YUMM1.7 tumor-bearing mice, based on flow cytometry for the following cell types: CD11b− CD11c+ F4/80+ alveolar
macrophages, CD11b+ CD11c− F4/80+ interstitial macrophages, CD11b+ CD11c+ F4/80+ dendritic cells, NK cells, NKT cells, CD4+ T cells, CD8+ T cells
(n= 12 male groups; n= 14 females). b Analysis of percent-activated immune cells by flow cytometry: CD69+ NKT cells, IFNγ+ NKT cells, CD4+CD44+
T cells, CD4+CD69+ T cells, CD8+CD44+ T cells, CD8+CD69+ T cells (n= 14 male groups; n= 16 females). Representative lung images (c) and tumor
colonies numbers (d) in the lungs of Rag1−/−male and female mice following B16 tail-vein injection. e–f Flow cytometry analysis of lung-infiltrating CD11b+
Ly6G+ neutrophils and (e: n= 16 per group; f: n= 15 male+sham, n= 16 male+castration, female) g–h CD69+ NK cells and IFNγ+ NK cells (g: n= 13 male
+sham, n= 15 male+castration, n= 11 female; h: n= 15 male+sham, n= 10 male+castration, n= 16 female). Ex vivo B16 cytotoxicity assays of lung
isolated (i) NK cells and (j) neutrophils from tumor-bearing mice at effector cell:target cell ratios of 3:1 and 6:1. Data in a–b, d–h, and i–j are mean ± s.e.m.
by 1-way ANOVA with Bonferoni post-tests analysis (a–b and e–h) or two-tailed unpaired t test (d). Data in a–b and e–h are representative of at least 3
independent experiments; data in c–d are representative of 2 independent experiments (n= 8 per group); data in i–j are representative of 2 independent
experiments (each point is from 3 pooled mice for an n= 15 per group). The scale bar represents 0.5 cm for images of lung.
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oxidative stress, and can cause DNA damage that can lead to
mutagenesis39. MPO is also a main component of neutrophil
extracellular traps (NETs). The formation of NETs is an addi-
tional important antimicrobial neutrophil function, and although
the role of NETosis in cancer is still unclear, we observed that
unstimulated neutrophils from ADT-treated patients produced
more NETs after plating for 1 and 3 h (Fig. 5h; Supplemen-
tary Fig. 5g). Taken together, neutrophils derived from prostate
a B16
6
4
2
%
C
D
3+
N
K
1.
1+
IF
N
γ+
%
 C
D
11
b+
 L
y6
G
+
 D
H
R
12
3+
(u
ns
tim
ul
at
ed
)
%
 C
D
11
b+
 L
y6
G
+
 D
H
R
12
3+
(P
M
A
 s
tim
ul
at
ed
)
M
F
IF
IT
C
 (
en
gu
lfe
d 
be
ad
s)
0
20
15
10
2400
2300
2200
2100
2000
0
5
0
ns
150
100
100
80
60
40
20
0
80
70
60
50
120
100
80
60
D
is
ta
nc
e 
of
 n
eu
tr
op
hi
ls
fr
om
 tu
m
or
 (
μm
)
40
20
ns
ns ns
ns350
300
250
200
150
B
16
 c
ol
on
ie
s 
in
 lu
ng
100
80
60
40
20
0
50
0
0
%
 C
D
11
b+
 L
y6
G
+
 D
H
R
12
3+
(P
M
A
 s
tim
ul
at
ed
)
40
0
B
16
 c
ol
on
ie
s 
in
 lu
ng
%
 m
at
ur
e 
ne
ut
ro
ph
ils
50
0
p = 0.0484
p = 0.0073
p = 0.04
p = 0.0088
p = 0.0152
p = 0.0021
p = 0.0068
p = 0.0054
p = 0.0286
p = 0.018
p = 0.0011
p = 0.0023 p = 0.0009 p = 0.0189
p < 0.0001 p < 0.0001
p < 0.0001 p = 0.0013
Male + lgG
Male + lgGMale + αLy6G
Male + αLy6G
Female + Ig
Female + IgG
Female
Male + sham
Male + castration
Female
Male + sham
Male + castration
Female
Male + sham
Male + castration
Female
Male + sham
Male + castration
Female
Male (sham)
Male (cast)
Female + αLy6G
Female + αLy6G
Male + lgG
Male + αLy6G
Female + IgG
Female + αLy6G
Male BM → M
Female BM → M
Female BM → F
Male BM → F
Male BM → M
Female BM → M
Female BM → F
Male BM → F
Male BM → M
Female BM → M
Female BM → F
Male BM → F
Male BM → M Female BM → M
B16
ns ns15
10
%
 C
D
11
b+
 L
y6
G
+
5
0
Female BM → F Male BM → F
b
d
e f
g
i j
h
k I
c
G
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-15397-4 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:1613 | https://doi.org/10.1038/s41467-020-15397-4 |www.nature.com/naturecommunications 7
cancer patients undergoing ADT appear to be constitutively
activated and may have a suppressive phenotype.
Discussion
In this report, we utilized multiple syngeneic metastatic mouse
models to elucidate the underlying cause of the well-documented
male-specific increase in incidence of melanoma with age. Fol-
lowing injection of either the spontaneous melanoma cell line B16
or the YUMM1.7 line, which harbors human driver mutations,
tumor burden was higher in female mice than male mice. While
ovariectomy surgery had no impact on the formation of meta-
static tumors, castration significantly increased tumor burden in
the lungs of male mice. Supporting a direct role for androgen
signaling in this effect, this phenotype could be completely
reversed with T replacement.
It is widely accepted that sex hormones influence the devel-
opment of immune cells and their responses, in a sex dependent
manner. In this study, immune profiling revealed that the
androgen-dependent protection from metastases was associated
with differences in neutrophil maturation and function. Fur-
thermore, neutrophil-depletion selectively impacted male mice,
increasing their tumor burden and resulting in decreased NK cell
activation. Previous studies have shown that the androgen
receptor is important for the development of neutrophils, as AR-
deficient mice have been shown to suffer from neutropenia due to
reduced proliferative activity of neutrophil precursor cells31. We
observed that castration resulted in a significantly decreased
percentage of peripheral neutrophils, in agreement with previous
studies31, which could be rescued in males and increased in
females via the administration of T. Thus neutrophils, which
express the androgen receptor, are greatly impacted by the change
in the hormonal environment in males when castration occurs.
The presence of the androgen receptor on the melanoma cells was
inconsequential in terms of metastatic potential, as both mela-
noma models exhibited the same phenotype, despite differential
AR expression by qPCR, although both cell lines were negative
for AR by western blot. Further, BMT experiments between sexes
did not reverse this phenotype, indicating the circulating hor-
monal level, rather than the sex of the immune cells, underlies the
effect on tumor metastasis.
The role of neutrophils in cancer remains under debate. Tumor
associated neutrophils (TANs) can have potent anti-tumor effects
through direct killing of tumor cells, antibody dependent cell
cytotoxicity, and recruitment of other immune cells with anti-
tumor activity40–42, but have also been associated with poor
prognosis43–45 and can promote metastasis, angiogenesis, and
tumor cell survival. In a UV-induced mouse model of melanoma,
an UV-induced neutrophilic inflammatory immune response
stimulated angiogenesis and increased migration of melanoma
cells46. The presence of neutrophils (CD66+) and plasmacytoid
dendritic cells (CD123+) in primary melanoma patient samples
have also been shown to be associated with poor prognosis47.
Further, neutrophils have also been shown to either inhibit or
promote metastasis through the formation of a pre-metastatic
niche48. In addition, some studies have found that neutrophils
may correlate with a worse melanoma outcome46,49. Subsequent
studies have divided neutrophils into two categories: N1 and N2.
N1 neutrophils are mature, non-suppressive, have pro-
inflammatory anti-tumor functions, and exhibit increased
expression of immune-activating cytokines and chemokines,
lower levels of arginase1, enhanced cytotoxic capabilities and are
capable of a potent oxidative burst48,50. N2 neutrophils are
immature, can suppress an anti-tumor response or exhibit pro-
tumor functions and support tumor growth by producing
angiogenic factors and matrix-degrading enzymes, and have
reduced migration, phagocytosis, and oxidative burst48,50. Animal
studies have shown that N1 anti-tumor neutrophils in the pre-
metastatic niche prevented breast cancer metastasis to the
lung40,51, while N2 immunosuppressive neutrophils in the pre-
metastatic niche promoted liver cancer metastasis from the
spleen52, breast cancer metastasis (in conjunction with IL-17
producing gamma delta T cells) to the lymph nodes and lung53,
and melanoma metastasis to the lung in nude mice injected via
tail vein with neutrophils and melanoma cells54. In the tumor
microenvironment, ROS has been shown both to promote tumor
development and progression, as well as cause ROS-induced
apoptosis in cancer cells48,55. Specifically, type I interferons (IFN)
have been shown to enhance the cytotoxicity of tumor associated
neutrophils through increased ROS production and NET for-
mation in mouse models, and this neutrophil activation was also
shown in melanoma patients undergoing type I IFN therapies56.
Thus, a delicate balance of ROS is required to create an anti-
tumor effect, which can be further enhanced by treatment with
Type I IFN55,56. In our studies, we observed decreased maturation
of neutrophils in the blood of castrated male and female mice,
which correlated with tumor burden. Changes in the RNA levels
of chemokine receptors were consistent with this maturation
defect, with bone-marrow derived neutrophils from tumor-
bearing castrated mice characterized by decreased CXCR2 and
increased CXCR4 and VLA4. Taken together, these data suggest
that the presence of mature neutrophils is indicative of an N1-
driven anti-tumor response.
It is likely that NK cells also play a role in this model. NK cell
depletion resulted in a significant increase in tumor burden in
both male and female mice in a sex-independent manner, indi-
cating that B16 melanoma cells are very susceptible to NK cell
killing. Furthermore, ex vivo studies showed increased cytotoxic
capabilities of NK cells compared with neutrophils. Neutrophil-
derived factors have been shown to have stimulatory effects on
NK cells, including enhancement of cytotoxic activity,
Fig. 3 Neutrophils from sham male tumor bearing mice have an anti-tumor effect. Representative lung images (a) and numbers of B16 colonies (b) in the
lungs of male and female mice treated with either control IgG or anti-Ly6G mAb (n= 8 male+IgG, male+αLy6G, female+IgG, n= 7 female+αLy6G.
c Percent IFNγ+ NK cells in lungs of male and female IgG control or anti-Ly6G treated mice (n= 5 per group). d Percent of lung neutrophils from tumor-
bearing mice that have a mature, segmented appearance morphologically (n= 18 per group; 3 pooled samples each). Percentage of lung neutrophils
producing DHR123 without stimulation (e) and after PMA stimulation (f) (n= 8 male+sham, n= 10 male+castration; n= 9 female). g FITC MFI of lung
neutrophils after engulfing FITC-labeled zymosan A S. cerevisiae beads (n= 5 per group). h Distance of neutrophils within 100 µM of a B16 tumor nodule in
the lung of sham male, castrated male, and female mice (n= 30 neutrophils/3 mice per male group, n= 44 neutrophils/4 female mice).Representative
lung images (i) and number of melanoma tumor colonies (j) in lungs of mice receiving a BMT from the opposite sex (n= 9 male to F and female to M, n=
8 female to F, n= 10 male to M). k Percent of lung-infiltrating neutrophils following a sex BMT (n= 8 male to F, n= 9 female to M, n= 8 female to F, n=
10 male to M). l Percent of lung neutrophils producing DHR123 with PMA stimulation following a sex BMT (n= 4 male to F, n= 14 female to M, n= 5
female to F, n= 14 male to M). Data in b–h and j–l are mean ± s.e.m. by 1-way ANOVA with Bonferoni post-tests analysis (b, c, e–h, and j–l) or z-score by
difference of two proportions (d). Data in a–c and h are representative of 2 independent experiments and data in d-g and j-l are representative of at least 3
independent experiments. The scale bar represents 0.5 cm for images of lung.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-15397-4
8 NATURE COMMUNICATIONS |         (2020) 11:1613 | https://doi.org/10.1038/s41467-020-15397-4 | www.nature.com/naturecommunications
enhancement of survival, induction of CD69, and upregulation of
CD11b57. However, granulocyte-derived ROS has inhibitory
effects on a number of NK-cell effector functions, consistent with
the increased percent of ROS-producing neutrophils from
unstimulated castrated male-tumor and female-tumor bearing
mice57. Further, mice specifically lacking mature neutrophils
(CD11b+Ly6Ghi) exhibit NK cell hypo-proliferation and poor
survival58. In our model, the combination of mature neutrophils
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and a decreased percent of ROS producing cells in sham male
mice resulted in increased NK cell activation and IFNγ-producing
cells, and ultimately, decreased lung tumor burden. While we did
not find any differences in the percentage or activation of lung-
derived T cells, Kissick, et al. previously showed that castration
led to increased infiltration of CD3+ cells in murine lungs and
decreased Th1 differentiation in both mouse and human prostate
cancer patients on ADT59, which warrants further investigation
of T cell differentiation in future studies.
We found that the addition of a physiological level of testos-
terone at the time of castration was able to reverse the increased
tumor burden phenotype in primary tumors and both the
experimental (tail vein injection) and spontaneous (subcutaneous
implantation) tumor models, and that low-dose testosterone also
Fig. 4 Testosterone signaling in immune cells impacts tumor burden. Representative lung tumor images (a) and number of lung tumor colonies in male
mice and male mice following castration with and without testosterone (T) replacement at physiological doses (b) (n= 7 male+sham, n= 8 male
+castration, n= 9 female). c Percent of neutrophils in lung following castration with and without T replacement (n= 10 male+sham, n= 12 male
+castration, n= 13 female). Weight of YUMM1.7 subcutaneous tumors (n= 10 male+sham, n= 9 male+castration, n= 10 male+castration+T, n= 9
female) (d) and number of spontaneous metastastic lung colonies (n= 9 male+sham, n= 7 male+castration, n= 9 male+castration+T, n= 8 female)
(e). Representative lung images (f) and number of lung tumor colonies (g) following a BMT with immune cells deficient in AR (ARTfm mice). Percentage of
neutrophils in the lungs of male mice receiving a BMT from either WT or ARTfm mice (h) (n= 10–15 per group). Percentage of DHR123-producing
neutrophils following ARTfm BMT without (i) and after PMA stimulation (j; n= 15M C57→M Ly5.1, n= 10M ARTfm→M Ly5.1). Representative lung images
(k) and number of B16 lung colonies (l) following implantation of either a placebo or slow-release flutamide pellet (n= 9 male+placebo, n= 8 male
+flutamide). Data in b–e, g–j, and l are mean ± s.e.m. by 1-way ANOVA with Bonferoni post-tests (b–e) analysis or two-tailed unpaired t test (g–j, l). Data
in a–c are representative of at least 3 independent experiments and data in d–l are representative of 2 independent experiments. The scale bar represents
0.5 cm for images of lung.
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Fig. 5 Analysis of neutrophils from control or androgen deprivation therapy (ADT) treated patients. a Percent of circulating neutrophils from control
or ADT treated prostate cancer patients that have a mature, segmented appearance morphologically. b Percent Cd11b+CD66b+CD16lo neutrophils.
c Percent myeloid derived suppressor cell (MDSC)-like neutrophils defined as HLA-DR−CD14−CD33+CD15+. d Percent fold change in migration (percent
crystal violet positive area of transwell stimulated with a chemoattractant divided by percent area without chemoattractant). e Percent of unstimulated
neutrophils producing DHR123. f Percent of neutrophils producing DHR123 following PMA stimulation. g Percent myeloperoxidase+ (MPO+) neutrophils.
h Percent of plated netosising neutrophils at 1 and 3 h following purification. Data in a–h are mean ± s.e.m., *p < 0.05, **p < 0.01, ***p < 0.001 by
multivariable linear regression using ADT as its main predictor and adjusting for presence of prostatectomy, age, race, and current status; control prostate
cancer patients (n= 8 in a, c, g and n= 7 in b, d, e, f, h) and prostate cancer patients receiving ADT (n= 22 in a, c, g and n= 21 in b, d, e, f, h).
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had a similar protective effect in female mice following a tail vein
injection with B16. Interestingly, super-physiological levels had
the opposite effect, consistent with the finding that men with high
T have a unique gene profile correlated with poor virus-
neutralizing activity60. In BMTs from ARTfm mice, we found
that expression of truncated AR in immune cells resulted in
increased B16-lung tumor burden, as well as increased ROS-
producing unstimulated cells and a weakened response when
stimulated. However, in this model the number of infiltrating
neutrophils in the lung was consistent between groups, thus the
difference in tumor burden may be explained by the decreased
number of mature neutrophils, as well as the increased percent of
ROS-producing cells, rather than by the number of
neutrophils alone.
Taken together, these data indicate a positive effect of phy-
siological levels of T on neutrophil function in a cancer setting. A
lack of AR signaling in the bone marrow prevents the maturation
of neutrophils and impedes homing to tumor-bearing lungs.
Once there, these immature neutrophils exhibit a pro-
tumorigenic effect with enhanced percentages of ROS produ-
cing cells, as well as suppression of NK activation and a reduced
percent of NK IFNγ-producing cells (Fig. 6).
To validate that this pathway exists in humans, we isolated
neutrophils from prostate cancer patients undergoing ADT
treatment. ADT patient-derived neutrophils exhibited an imma-
ture, potentially MDSC-like suppressive phenotype, produced
more MPO and NETs, and displayed decreased CD16 positivity.
ADT is a main line of therapy for metastatic prostate cancer
patients and most cancers initially respond61. Thus, the effect of
androgen deprivation on the immunosuppressive capacity of
neutrophils may not be relevant to prostate cancer progression.
However, patients on ADT have an average time to failure of
11 months and an overall survival of 42 months61. With the
recent emergence of immunotherapy for the treatment of many
solid tumors, the use of checkpoint therapies for castration-
resistant metastatic prostate has become increasingly intriguing.
Based on these data in this study, it may be important to carefully
consider how ADT can be combined with immune checkpoint
blockade therapy. While some studies have shown that ADT
results in an increased number of infiltrating CD3 T cells, CD4
T cells, CD8 T cells, NK cells, and macrophages in prostate tissue,
as well enhanced T cell proliferation, other studies have shown
that AR blockade actually impairs immunotherapy by preventing
initial T-cell activation59,62,63. Our finding that ADT had an
adverse effect on the maturity and anti-tumor potential of neu-
trophils, raises the question of whether ADT might further
exacerbate a suppressive microenvironment and impact the effi-
cacy of combination therapy with ADT and checkpoint blockade.
Further, certain combinations of ADT with immunotherapy may
exhibit better clinical efficacy, i.e., the use of androgen synthesis
blockade over an AR antagonist, or the use of ADT after a
positive clinical benefit with immunotherapy is already ongoing,
rather than concurrent treatment.
Together, these results provide a better understanding of
androgen signaling in neutrophils and the potential impact that
ADT therapy in prostate cancer patients has on these cells.
Further studies to understand this androgen-myeloid cell inter-
action are warranted, and a consideration of this phenomenon
may be important when combining ADT and immunotherapy for
prostate cancer patients. It may be tempting to speculate that
androgen ablation therapy used in certain cancers such as pros-
tate cancer may alter neutrophil function due to hormonal
changes in the microenvironment and may increase risk of skin
cancer such as melanoma, but such correlations remain to be
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Fig. 6 Impact of testosterone on neutrophil phenotype using a representative B16-tumor model. In castrated male mice, testosterone is diminished and
can no longer activate the androgen receptor (AR). This causes a decrease in CXCR2, CD62L, and STAT3 expression, and an increase in CXCR4 and VLA4
expression. These changes lead to more banded, immature neutrophils and an overall reduced number of neutrophils in circulation. Once B16 cells are
injected via tail vein and allowed to metastasize to the lung, castrated male mice have a poor recruitment of mature, segmented neutrophils which leads to
an increase of ROS-producing neutrophils, fewer NK+ IFNγ-producing cells, and results in increased tumor burden and decreased survival compared with
sham-operated male mice.
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established in humans. In addition, while men and women
initially have a similar incidence of melanoma, the risk rises in
males dramatically after age 504, correlating with an age-
dependent drop in testosterone level64 and in line with our
observations in castrated mice. While our data do not explain
why males with melanoma have worse progression free survival
and overall survival, our data do indicate that it may be inter-
esting to look further at aging males, who have lower levels of
testosterone, to see if hormones exert an effect on immune
defense against cancer. Thus, it may be beneficial to assess hor-
mone levels in this subset of melanoma patients and elucidate the
impact that neutrophils may have on the progression of cancer.
Further studies to assess function of neutrophils in patients suf-
fering from low T are also warranted.
Methods
Mice. C57BL/6, Ly5.1, Rag1−/−, Ldlr−/−, and B6.Cg-Aw-J EdaTa-6J+/+ArTfm/J
mice were purchased from Jackson Laboratory. Age and sex matched controls were
used for all of our studies. The mice were housed in a 12-h light: dark cycle at
22 °C–25 °C temperature with relative humidity of 50–70 percent, and given ad-
libitum access to food and water for the duration of the study. Mice were housed in
specific-pathogen-free conditions and cared for in accordance with US National
Institutes of Health guidelines, and all procedures were approved by the Cedars-
Sinai Animal Care and Use Committee. The number of animals used in various
experiments ranged between 5 and 13 in each group, as specified in the legend of
each figure.
Cells and tumor models. The mouse melanoma cell line B16F10 was obtained
from ATCC® (CRL-6475) and was maintained in Dulbecco’s Modified Eagle’s
Medium (DMEM) supplemented with 10% fetal bovine serum (FBS), penicillin
(100 U/ml), and streptomycin (100 μg/ml). The mouse melanoma cell lines
YUMM1.7 and YUMM3.1 were a generous gift from Marcus Bosenberg (Yale
University, New Haven, CT). These cell lines were created from the genetically
engineered mouse model of inducible melanoma harboring the following muta-
tions: BrafV600E; Cdkn2a−/−; (YUMM1.7 and YUMM3.1) and Pten−/− (YUMM1.7
only). These mice, B6.Cg-Braftm1Mmcm Ptentm1Hwu Tg(Tyr-cre/ERT2) 13Bos/
BosJ, are available for purchase at Jackson Laboratory. The cells were maintained in
RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS), penicillin
(100 U/ml), and streptomycin (100 μg/ml).
For lung metastatic models, B16 (2 × 105), YUMM1.7 (5 × 105), or YUMM3.1
(4 × 105) cells were injected via tail vein and were enumerated visually facilitated by
the use of a magnifying glass and a lamp or by extracted melanin determined by
spectrophotometry (for B16 only). To extract melanin, the entire left lobe was
homogenized and digested in 300 μL of PBS. After centrifugation for 10 min at max
speed, the supernatant was removed. The samples were then processed in 1 mL of
lysis buffer containing 1M tris-Hcl, 10%SDS, 0.5 M EDTA, 10 μg/mL Proteinase K,
and water in a 56 °C shaker until completely dissolved. This process can take up to
48 h and was aided by the addition of additional proteinase K and processing
through an 18-gauge needle. Once the melanin was dissolved, samples were
centrifuged for 10 min at max speed and the supernatant discarded so that a black
pellet remained at the bottom. 200 μL of 2 N NaOH was added and the sample
placed in a shaker at 95 °C overnight or until completely re-dissolved. Then, 100 μL
of 2 chloroform:1 methanol was added and the sample mixed well before being
centrifuged for 10 min at max speed. 100 μL of the top layer was read on a
SpectraMax spectrophotometer: OD405-OD570. Resulting values were analyzed
directly. For YUMM1.7 and YUMM3.1 tumors, lungs were injected with India ink
and then destained using Fekete’s solution so that tumors appeared white in color.
For subcutaneous tumors, 2 × 105 B16 or 2.5 × 105 YUMM1.7 cells were injected
into the right flanks of C57BL mice and were measured with calipers; size was
expressed as one-half the product of perpendicular length and square width in
cubic millimeters. For survival studies, mice were euthanized when endpoint
criteria of a Body Condition Score <2 were met. For high fat diet studies, 6-week
old Ldlr−/− mice were placed on a Western Diet containing 21% fat and 0.2%
cholesterol with 42% of calories coming from fat (Harlan Teklad, TD88137)
consumed ad libitum for 12 weeks prior to inoculation of tumor cells and
continued until sacrifice. Serum cholesterol levels were quantified using an
enzymatic colorimetric test of total cholesterol according to the manufacturer’s
protocol (Cholesterol E, Wako, 439-17501).
Histopathological analysis. Lungs were fixed in formalin, parrafin-embedded,
and sectioned. For immunohistochemistry of neutrophils, slides were stained with
anti-Ly6G monoclonal antibody (mAb) (Clone 1A8, BP0075, Bio X Cell) or control
rat IgG (14131, Sigma) at 1:50 overnight at 4 °C. Slides were washed with PBS 3×
and stained with donkey-anti-rat IgG (AlexaFluor594, Thermofisher Scientific, A-
21209) at 1:500 for 1 h at room temperature. Slides were then washed 3× with PBS
and were mounted with ProLong Gold antifade reagent with DAPI (Invitrogen,
P36931). Images were obtained on a Keyence BZ-9000 microscope using ×20
magnification (Keyence). Neutrophils were identified by positive Ly6G staining and
the distance from the neutrophil to the closest B16 tumor edge was calculated using
the Keyence software. Neutrophils within 100 µM of a tumor nodule were inclu-
ded65. Corresponding H&E stains (MilliporeSigma, hematoxylin HHS32 and eosin
230251) of sequential tissue samples were used to confirm the location of B16
tumor nodules.
Cell specific depletions. In vivo neutrophil depletion was performed by intra-
peritoneal (i.p.) injection of 500 μg sterile anti-Ly6G monoclonal antibody (Clone
1A8, BP0075, Bio X Cell) or control rat IgG (14131, Sigma) to both female and
male C57BL/6 mice beginning one day prior to tumor inoculation and was con-
tinued to maintain depletion throughout the tumor study (days-1, 1, 4, 8, and 11).
Depletion of neutrophils (Gr1hi) in lungs was confirmed by flow cytometry at the
time of sacrifice.
NK cell depletion was performed by i.p. injection of 200 μg sterile anti-NK1.1
mAb (Clone PK136, BE0036, Bio X Cell) or control mouse IgG (I5381, Sigma-
Aldrich) to both female and male C57BL/6 mice beginning one day prior to tumor
inoculation and was continued to maintain depletion throughout the tumor study
(days-1, 1, 4, 8, and 11). Depletion of NK1.1 cells in lungs (NK1.1+CD49b+) was
confirmed by flow cytometry at the time of sacrifice.
Ovariectomy. Four weeks prior to tumor inoculation, 8-weeks-old C57BL/6 mice
underwent ovariectomy or sham-surgery. Mice were maintained on inhalation
anesthesia (1.5% Isoflurane) via nose-cone. Prior to the start of the surgery, car-
profen (5 mg/kg body weight) was administered subcutaneously. The area below
the ribs was shaved and cleaned with betadine followed by alcohol. This area was
then lifted with forceps to make a small 2 mm horizontal cut. Resorbable vicryl
sutures were used to clamp the horn beneath the ovary and each ovary was
removed using forceps and scissors. The uterine horns were then placed back into
the body and the peritoneal cavity was closed using interrupted resorbable vicryl
sutures. The skin was closed with interrupted nylon sutures. Following sponta-
neous movement, buprenorphine (0.5 mg/kg body weight) and 300 µL of warm
saline were administered subcutaneously. In sham operated mice, both the skin and
inner skin membrane were incised. The ovaries were externalized and returned to
the abdominal cavity and the wound was sealed with interrupted nylon sutures.
Castration and testosterone implantation. Four weeks prior to tumor inocula-
tion, C57BL/6 mice of 8 weeks of age were castrated or sham-operated. Mice were
maintained on inhalation anesthesia (1.5% Isoflurane) via nose-cone. Prior to the
start of the surgery, carprofen (5 mg/kg body weight) was administered sub-
cutaneously. The area between the penis and the anus was shaved and cleaned with
betadine followed by alcohol to disinfect the scrotum. The area between the penis
and the anus were lifted to make a small 1 mm horizontal cut. To remove the testes,
a small 1 mm cut into the inner skin membrane enclosing the testicles was made
and the testicles were exteriorized. Testicular arteries were tied off using resorbable
vicryl sutures prior to removing the testes. Once the testes were removed, the
wound was sealed with two nylon sutures. Following spontaneous movement,
buprenorphine (0.5 mg/kg body weight) and 300 µL of warm saline were admi-
nistered subcutaneously. In sham operated mice, both the skin and inner skin
membrane between the penis and anus were incised. The testes were drawn out and
placed back and the wound was sealed with interrupted nylon sutures.
For hormone replacement, at the time of castration, testosterone pellets (1.5 mg
or 50 mg dose, 60 day release, SA-151; Innovative Research of America) or placebo
pellets (1.5 or 50 mg dose, 60 day release, SC-111; Innovative Research of America)
were implanted subcutaneously. For the flutamide studies, 8 week old male and
female mice were implanted with either a placebo pellet or a flutamide pellet (100
mg, 21 day release, A-152; Innovative Research of America) one week prior to B16
implantation. Hair from a small area behind the neck was removed with electric
clippers and cleaned with betadine followed by alcohol. A small incision was made
and a pellet (1 cm × 1 cm in size) containing testosterone or biodegradable matrix
(placebo) were implanted subcutaneously on the lateral side of the neck between
the ear and shoulder. The wound was closed with interrupted nylon sutures.
Bone marrow transfer. C57BL/6 or Ly5.1 mice at 8 weeks of age were lethally
irradiated once with 950 rads using a 137Cesium gammacell source (Gammacell 40
Cs γ-irradiation; GammaCell Bio-Technologies). Four hours post irradiation, 1 ×
107 cells were injected via tail vein under brief anesthesia while in a mouse
restraint. The bone marrow cells were collected by flushing the femurs of donor
mice (C57BL/6, ArTfm, or Ly5.1) under sterile conditions and were prepared as a
single cell suspension using a 70 μM nylon filter (BD, Falcon, 352250). The
immune system was allowed to reconstitute for 8–12 weeks before tumor cells were
injected. Complete bone marrow reconstitution was confirmed by flow cytometry
analysis of the expression of CD45.2/Ly5.2 (from C57BL/6 mice) and CD45.1/Ly5.1
(from Ly5.1 mice).
Complete blood count. Fifty microliter of mouse blood was collected via retro-
orbital bleeding in an EDTA coated tube and was processed the same day. A
complete blood count/differential was performed by the Division of Laboratory
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Medicine at UCLA (Los Angeles, CA) on a Drew Scientific HemaVet hematology
analyzer.
Testosterone level quantification. Mouse serum was obtained at the time of
sacrifice and testosterone levels were assayed using a commercially available Tes-
tosterone EIA kit (582701; Cayman Chemical) according to the manufacturer’s
protocol.
Quantitative real-time PCR. Total RNA was extracted by RNeasy extraction kit
(Qiagen) and reverse transcribed using PrimeScript RT Reagent Kit (Takara Bio)
according to the manufacturer’s protocols. Real-time polymerase chain reaction
(qPCR) was performed using SYBR Green Master Mix (Takara Bio) and was run
on a CFX96 Touch Real-Time PCR Detection System (BioRad). GAPDH or beta
actin served as a loading control. The following primer sequences were used for
cDNA quantification: AR fwd 5’-GCCTCCGAAGTGTGGTATCC-3’, rev 5’-TGG
TCCCTGGTACTGTCCAA-3’; Cxcr2 fwd 5’-GGTGGGGAGTTCGTGTAGAAG3’,
rev 5’-CTACTACACAGGGATCAGGGC-3’; Cxcr4 fwd 5-GCCATGGAACCGAT
CAGTGTGA-3’, rev 5’-GATGAAGTAGATGGTGGGCAGG-3’; L-sel (CD62L) fwd
5’-TACTGGGGCTCGAGGAACAT-3’, rev 5’-TCCCAGTTCATGGGCTTTTCA-3’;
Nfkb2 fwd 5’-CGCCTCTCTTCACCTTAGGC-3’, rev 5’-CAGGCCTGGATCGTAG
CAAT-3’; Rab4a fwd 5’-GAGAAACCAAGAACTGCCCCT-3’, rev 5’-AGCGCATT
GTAGGTTTCTCG-3’; Rel fwd 5’-GAGAAACCAAGAACTGCCCCT’3’, rev 5’-AA
CTCCTGAAGACCTGGGCA; Stat3 fwd 5’-ATGGATGCGACCAACATCCT-3’, rev
5’-CAATGGTATTGCTGCAGGTCG-3’; VLA4 fwd 5’-TTGGCTACTCGGTGGTG
CTG-3’, rev 5’-ATGTCTTCCCACAAGGCTCTC-3’.
RT2 profiler PCR array. Neutrophils from lungs or prostate lobes were isolated
from sham male and castrated males and were pooled with 5–6 mice per group.
RNA was extracted using an miRNA extraction kit (miRNeasy, Qiagen, 217004).
Synthesis of cDNA was performed using the RT2 First Strand Kit (Qiagen, 330401)
and cDNA was amplified using the RT2 PreAMP cDNA synthesis kit (Qiagen,
330451) and AR pathway primer mix (Qiagen, PBM-142Z) for neutrophils. The
RT2 Profiler PCR Array Mouse Androgen Receptor Signaling Targets (Qiagen,
330231, PAMM-142ZD-2) plates were run on a CFX96 Touch Real-Time PCR
Detection System (BioRad). All steps were performed according to the manu-
facturer’s protocol.
Western blot. B16, YUMM1.7, and LnCaP cells (ATCC, clone FGC, CRL-1740)
were pelleted and lysed in ice-cold Lysis buffer consisting of Tris (25 mM; Bio Rad;
catalog 161-0719), Triton x-100 (1%; Sigma: catalog T8787), Glycerol (10%; Fisher
Scientific; catalog BP229-1), EGTA (4 mM; Sigma; catalog E-4378), pH adjusted
to 7.8 with dilute o-phosphoric acid. The lysates were passed 5 times through a
25-gauge needle for complete homogenization. Mouse testes were mechanically
homogenized using an 18-gauge needle in ice-cold lysis buffer. Testes homogenates
were then centrifuged at 10,000×g for 10 min at 4 °C to remove unbroken cells and
debris. Protein quantification was performed on supernatants using bicinchoninic
copper assay (ThermoFisher Scientific, catalog 23225). Equal masses of protein
were loaded in 10% SDS page gels and transferred overnight at 30 V to a PVDF
membrane (ThermoFisher Scientific, catalog 88518) at 4 °C. The membrane was
cut below the 63 kDa and anti-AR (Santa Cruz Biotechnology, catalog sc-7305; top
portion of membrane) and anti-β-Actin (Sigma, catalog A5316; bottom half of
membrane) antibodies were diluted at a concentration of 1:500 and 1:10,000,
respectively, in blocking buffer consisting of 5% nonfat dry milk (Bio Rad, catalog
1706404) dissolved in TBS-T. HRP-conjugated goat anti-mouse (Jackson Immu-
noResearch, catalog 115-035-003) secondary antibodies were diluted at a con-
centration of 1:10,000 in blocking buffer. Chemiluminescent substrate
(ThermoFisher Scientific, catalog 34577) was applied to membranes, and bands
were imaged via Bio-Rad Chemidoc (Bio-Rad).
Human study population. Informed consent and blood samples were collected
under Cedars‐Sinai Medical Center Institutional Review Board-approved
Pro00042197. For this study, a separate IRB-approved protocol (Pro00047412) was
obtained to specifically study neutrophils. Patient ages ranged from 52-80 years
(median 72). The patients were white (n= 16), black (n= 5), other (n= 2), Asian
(n= 5), Hispanic (n= 1), and American Indian (n= 1). Patient samples were
classified into two categories: patients not receiving any current treatment and
patients undergoing active androgen deprivation therapy. Supplementary Table 1
indicates clinical characteristics of each patient sample used in this study.
Neutrophil and NK cell isolation. To isolate murine neutrophils or NK cells from
the bone marrow, spleen, or lungs, an EasySep Positive PE Selection Kit (19762 A)
or Negative Selection Mouse Neutrophil Enrichment Kit (18557) was used
according to the manufacturer’s protocols (Stemcell Technologies). The PE murine
antibody used was Ly6G (1 A8; BioLegend, 127608) or NK (PK136; BioLegend,
108707). Samples were pooled from 3-5 mice for each independent experiment and
purity was confirmed if >93% by flow cytometry or by Siemens Diff-Quik Stain Set
(B4132-1A, Fisher Scientific).
For human neutrophil isolation, peripheral blood mononuclear cells (PBMC)
were removed using SepMate tubes and the Lymphoprep density gradient
according to the manufacturer’s protocol (85450;07801 StemCell Technologies).
Once the PBMCs were removed, the pelleted blood was transferred to a new tube
and the red blood cells were lysed using 1X RBC lysis buffer (eBioscience). Cells
were stained using the Siemens Diff-Quik Stain Set to confirm >94% purity. Cells
were maintained in Endothelial Basal Medium-2 (EBM2, CC-3156, Lonza) which
was confirmed to not activate neutrophils.
Cytotoxicity assays. B16 cells were plated 24 h prior to the experiment at 5 × 103
per well in a 96 well flat bottom plate. Neutrophils or NK cells were isolated
from the lungs of B16 tumor-bearing mice (pooled 3 mice/sample) and were
co-cultured with the B16 cells for 4 h at effector:target ratios of 3:1 and 6:1 with
blank wells, effector only or target only serving as controls. All supernatant was
removed and remaining adherent B16 cells were fixed with 4% paraformaldehyde
overnight at 4 °C. Fixing solution was then discarded and 100 µL/well of crystal
violet stain was added and plate was placed on a rocker for 30 min. Plates were then
washed under running DI water for 15 min. The crystal violet was dissolved by
adding 100 µL/well of 10% acetic acid with rocking and plate was read at absor-
bance 600 on a SpectraMax M2 spectrophotometer.
Neutrophil scoring. Isolated neutrophils were transferred to slides using a Cytospin
4 centrifuge (Thermo Fisher Scientific) and were stained with the Siemens Diff-Quik
Stain Se (Thermo Fisher Scientific) to visualize neutrophil maturation based on
nucleus morphology25. Each subpopulation of neutrophils was assigned an arbitrary
number of 1 having a banded nuclei (immature) or 2 having a segmented nuclei
(mature). Images were obtained on a Keyence BZ-9000 microscope using 40x mag-
nification (Keyence). Greater than 150 neutrophils per sample were scored by two
investigators and scores were only included if both investigators were in agreement.
Flow cytometry. The same lobe of the lung was manually digested in a lysis buffer
containing HBSS, collagenase Type IV (2 µg/mL; 17104019; Thermo Fisher Sci-
entific), and DNAseI (25 units/mL; 10104159001; Sigma-Aldrich) with two 10 min
incubations at 37 °C. Samples were centrifuged for 5 min at 3000 RPM and the red
blood cells were lysed using 1X RBC lysis buffer (eBioscience). Single cell sus-
pensions were obtained from the digested lung and were incubated with FcBlock
(CD16/CD32, Clone 2.4G2; 70-0161-M001; Tonbo Biosciences). The following
murine antibodies against the respective antigens were used for flow cytometry at
1:50 concentration: neutrophils: Ly6G (1A8; PE; BioLegend, 127608) or Ly6G (Gr-
1; PE; eBioscience, 12-5931-82); macrophages: CD11b (M1/70; PerCP-Cy5.5;
Tonbo Biosciences, 35-0112) and F4/80 (BM8.1; APC; Tonbo Biosciences, 20-
4801); dendritic cells: CD11b and CD11c (N418; vF450; Tonbo Biosciences, 75-
0114); CD4 T cells: CD4 (RM4-5; APC; Tonbo Biosciences, 35-0042); CD8 T cells:
CD8a (Ly-2; PerCP-Cy5.5; eBioscience, 15-0081-82); natural killer cells: NK1.1
(PK136; APC; eBioscience, 17-5941-82) or CD49b (DX5; PE; eBioscience); CD69
activation marker: CD69 (H1.2F3; PE; eBioscience, 12-0691-83); BMT confirma-
tion: CD45.1 (A20; PerCp-Cy5.5; eBioscience, 45-0453-80) and CD45.2 (104; FITC;
Tonbo Biosciences, 35-0454) and cells were fixed with 2% paraformaldehyde. For
intracellular protein staining, the cells were washed and resuspended in permea-
bilization buffer (eBioscience, 00-5523) and stained by antibodies in the permea-
bilization buffer for 1 h on ice in the dark. The cells were then pelleted and
resuspended in the flow cytometry staining buffer for flow cytometry analysis.
For the analysis of human neutrophils, FcR blocking antibody (130-059-901,
MACS Miltenyi Biotec) was used at a concentration of 20 μL/107 cells. The
following human antibodies were used: Cd11b (ICFR44; PE, Tonbo Biosciences,
50-0118-T100), CD14 (HCD14;APC/Cy7, BioLegend, 325620), CD15 (MMA;
APC, eBioscience, 17-0158-42), CD16 (CB16; Alexa Fluor 700, eBioscience, 56-
0168-42), CD33 (P67.6; eFluor 450, eBioscience, 48-0337-42), CD45 (HI30;
violetFluor 450, Tonbo Biosciences, 75-0459-T100), CD66b (G10F5; APC,
eBioscience, 17-0666-42), HLA-DR (L243; FITC, Tonbo Biosciences 35-9952-
T100), Mouse IgG1 K IsoControl (P3.6.2.8.1; eFluor 450, eBioscience, 48-4714-82),
and MPO (MPO455-8E6; eFluor 450, eBioscience, 48-1299-42).
For ROS staining, cells were incubated with 0.5 μg/mL dihydrorhodamine 123
(DHR123, CAS 109244-58-8; Santa Cruz Biotechnology) for 5 min with agitation at
37 °C and either remained unstimulated or were stimulated with 0.3 μM of phorbol
myristate acetate (PMA) for 30 min at 37 °C. Following incubation, cells were
washed and stained with CD11b and Ly6G (1A8) antibodies for murine cells or
CD11b, CD45, CD66b and CD16 for human cells and were assessed by flow
cytometry. Stained cells were analyzed on an LSRII Fortessa (BD Biosciences) and
data were processed using FlowJo, version 10.5 (Tree Star Inc.).
Phagocytosis assay. Neutrophils from the lungs of B16-tumor bearing mice were
plated at 2.5 × 105/well in a 24 well plate and 5 µL/well of FITC-labeled zymosan A
S. cerevisiae beads (ThermoFisher Scientific, Z2841) were added. Following a brief
spin, cells were incubated for 30 min at room temperature. The media was removed
and the wells were washed with PBS. The cells were lifted by incubating for 15 min
in PBS/5 mM EDTA/1 mM sodium azide plus proteinase K to cleave any beads on
the surface of the cells. The cells were then stained for neutrophil markers as above
and analyzed by flow cytometry.
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NETosis staining. NETosis was induced in 2.5 × 104 neutrophils suspended in 250
μL of EBM2 media in 8-well Millicell EZ glass chamber slides (Millipore,
PEZGS0816). Briefly, unstimulated cells were maintained in a 37 °C incubator for 1
and 3 h and then fixed with 4% paraformaldehyde. The slides were washed with
sterile PBS three times for 5 min each and then stained with 1:2000 SYTOX orange
(ThermoFisher Scientific, S11368) and 1:500 MPO (Abcam, ab9535) for 1 h at
37 °C. Slides were then washed 3× with PBS for 5 min each and then stained with
1:500 Goat pAb to Rb IgG (Abcam, ab 150077) for 1 h at room temperature. Slides
were washed with PBS 3×, the chamber slide was removed according to the
manufacturer’s protocol and the slides were mounted with ProLong Gold antifade
reagent with DAPI (Invitrogen, P36931). Four images of each time point were
obtained on a Keyence BZ-9000 microscope at ×40 magnification. The total
number of cells was automatically calculated with the Keyence BioAnalyzer soft-
ware and the number of neutrophils was counted by a blinded scientist. The
percentage of NETosing neutrophils was calculated as an average of the number of
NETs divided by total number of cells/per image.
Invasion and migration assay. Corning transwells polyester membranes (6.5 mM,
3.0 μM pore size, Sigma Aldrich, CLS3472) were coated with human fibronectin at
10 μg/mL (Sigma Aldrich, F089S) for 1 h at 37 °C. Wells were then washed 2× with
sterile PBS and dried overnight. For invasion/migration assays, the bottom
chamber contained 600 EBM2 media μL with or without 100 nM N-formyl-met-
leu-phe (Sigma Aldrich, 47729-10mg-f) as a chemoattractant. Neutrophils (2.5 ×
104) suspended in 200 µL of EBM2 media were placed in the upper chamber and
were allowed to migrate for 2 h at 37 °C. Membranes were carefully aspirated,
washed twice with PBS and stained with crystal violet for 10 min and rinsed with
water until clear. Five images of each transwell were obtained on a Keyence BZ-
9000 microscope at ×40 and the area of crystal violet was analyzed using the
Keyence Bioanalyzer software. The results from 5 images were averaged together
and a percent change in migration was calculated by dividing the percent area of
transwell stimulated with a chemoattractant divided by percent area without
chemoattractant for each individual patient.
Statistical analysis. All statistical analyses were performed using GraphPad Prism
6.0. Data are presented as mean ± SEM. For selection of appropriate statistical tests,
recorded experimental data were subjected to the D’Agostino-Pearson omnibus test to
detect normal, Gaussian distribution. 2-tailed Student’s t test or 1-way ANOVA
(Tukey’s post-test) were used for comparisons of parameters among two or three
groups, respectively. The non-parametric Mann-Whitney U test was substituted for
the student’s t test when data did not follow a normal distribution. For neutrophil
maturation studies, the t test for two independent proportions was used. For patient
data, a multivariable linear regression analysis with adjustments for presence of
prostatectomy, age, race and current status was performed by the Biostatistics Core at
Cedars Sinai. White blood cell count was not available for analysis and thus was not
controlled for. The value of p < 0.05 was considered statistically significant. *p < 0.05,
**p < 0.01, and ***p < 0.001. Statistical parameters can be found in the figure legends.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The authors declare that the data supporting the findings of this study are available
within the paper and its Supplementary Information or from the authors upon
reasonable request.
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